ArticleCell death and differentiation2024

PD-L2 drives resistance to EGFR-TKIs: dynamic changes of the tumor immune environment and targeted therapy.

Simeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.